Gilead Sciences, Inc. and Pharmasset, Inc. announced that the companies have signed a definitive agreement under which Gilead will acquire Pharmasset for $137 per share in cash.
Continue reading “Gilead Sciences to Acquire Pharmasset, Inc. for $11 Billion”
Scientists have identified a protein that acts as a ‘master switch’ in certain white blood cells, determining whether they promote or inhibit inflammation .
Continue reading “Scientists find the ‘master switch’ for key immune cells in inflammatory diseases”
DeveloGen AG announced that it will receive US$ 500,000 from the Juvenile Diabetes Research Foundation, New York, USA (JDRF). The funds are dedicated to aide in the research of mechanisms for the protection of beta cells.
Continue reading “DeveloGen AG receives US$ 500.000 Funding from the Juvenile Diabetes Research Foundation for Beta Cell Research”
The MS Society and the UK Stem Cell Foundation (UKSCF) formally marked the beginning of a collaboration by announcing a call for research grant applications that can now dip into a dedicated pot of joint-funding up toGBP1million.
Continue reading “UK Stem Cell Foundation & MS Society Stem Cell Research Collaboration”
Clavis Pharma ASA announced that the Company has raised NOK 129 million (equivalent to USD 20 million) in gross proceeds through a private placement of 10,750,000 new shares, each with a par value of NOK 1.00 at a price of NOK 12.00 per share.
Continue reading “Clavis Pharma raises USD 20 million in a private placement to fund further development of its anticancer drug pipeline”